NO932057L - Ny dopamin-menneske-reseptor og dens anvendelser - Google Patents
Ny dopamin-menneske-reseptor og dens anvendelserInfo
- Publication number
- NO932057L NO932057L NO93932057A NO932057A NO932057L NO 932057 L NO932057 L NO 932057L NO 93932057 A NO93932057 A NO 93932057A NO 932057 A NO932057 A NO 932057A NO 932057 L NO932057 L NO 932057L
- Authority
- NO
- Norway
- Prior art keywords
- dopamin
- human
- applications
- new
- human receptor
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
- C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/9413—Dopamine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/626,618 US5422265A (en) | 1990-12-07 | 1990-12-07 | DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells |
| PCT/US1991/009308 WO1992010571A1 (en) | 1990-12-07 | 1991-12-06 | Human dopamine d4 receptor and its uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO932057D0 NO932057D0 (no) | 1993-06-04 |
| NO932057L true NO932057L (no) | 1993-08-09 |
| NO311363B1 NO311363B1 (no) | 2001-11-19 |
Family
ID=24511138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19932057A NO311363B1 (no) | 1990-12-07 | 1993-06-04 | DNA-sekvens som koder for en dopamin-menneske-reseptor-D4, homogen sammensetning inneholdende reseptoren, anvendelse avnukleotidsekvensen, samt ekspresjonsvektor og cellekulturomfattende nukleotidsekvensen og anvendelse av ekspresjonsve |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5422265A (no) |
| EP (1) | EP0574406B1 (no) |
| JP (1) | JP2966093B2 (no) |
| AT (1) | ATE196925T1 (no) |
| AU (1) | AU652211B2 (no) |
| CA (1) | CA2097698C (no) |
| DE (1) | DE69132447T2 (no) |
| DK (1) | DK0574406T3 (no) |
| FI (1) | FI932573L (no) |
| NO (1) | NO311363B1 (no) |
| WO (1) | WO1992010571A1 (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277591B1 (en) | 1988-11-18 | 2001-08-21 | Oregon Health Science University | Dopamine receptors and genes |
| US5569601A (en) * | 1990-12-07 | 1996-10-29 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University | Human dopamine receptor and its uses |
| EP0625990B1 (en) * | 1991-10-16 | 1998-07-29 | Chiron Corporation | Glycoprotein complexes and glycoproteins |
| US5766948A (en) * | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
| US6486310B1 (en) * | 1993-01-28 | 2002-11-26 | Washington University | Gene encoding the rat dopamine D4 receptor |
| US5576319A (en) * | 1993-03-01 | 1996-11-19 | Merck, Sharp & Dohme Ltd. | Pyrrolo-pyridine derivatives |
| SK106395A3 (en) * | 1993-03-01 | 1995-12-06 | Merck Sharp & Dohme | Treating and treatment or prevention of mental diseases |
| US5622950A (en) * | 1993-03-01 | 1997-04-22 | Merck, Sharp & Dohme Ltd. | Pyrrolo-pyridine derivatives |
| US5468615A (en) * | 1993-07-01 | 1995-11-21 | The Upjohn Company | Binding assay employing a synthetic gene for D4 dopamine receptors |
| WO1995009237A2 (en) * | 1993-09-28 | 1995-04-06 | Allelix Biopharmaceuticals Inc. | Expression of human d4 dopamine receptors in stable cell lines |
| US5994503A (en) * | 1995-03-27 | 1999-11-30 | Yale University | Nucleotide and protein sequences of lats genes and methods based thereon |
| US6531314B1 (en) * | 1996-12-10 | 2003-03-11 | Merck & Co., Inc. | Growth hormone secretagogue receptor family |
| ATE438717T1 (de) * | 1996-06-05 | 2009-08-15 | Novartis Vaccines & Diagnostic | Dp-75 kodierende dna und verfahren zu ihrer verwendung |
| AUPO427596A0 (en) * | 1996-12-20 | 1997-01-23 | Cooperative Research Centre For Tropical Plant Pathology | Anti-microbial protein |
| WO2000009538A2 (en) | 1998-08-10 | 2000-02-24 | Merck & Co., Inc. | Canine growth hormone secretagogue receptor |
| US6783973B1 (en) | 2000-09-12 | 2004-08-31 | Oregon Health & Science University | Mammalian catecholamine receptor genes and uses |
| US7381542B2 (en) * | 2001-07-09 | 2008-06-03 | Oregon Health & Science University | Nucleic acids encoding a biogenic amine receptor |
| WO2006116874A1 (en) * | 2005-05-05 | 2006-11-09 | Centre For Addiction And Mental Health | Compositions and methods for modulating dopamine neurotransmission |
| WO2009149560A1 (en) * | 2008-06-12 | 2009-12-17 | Centre For Addiction And Mental Health | Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
-
1990
- 1990-12-07 US US07/626,618 patent/US5422265A/en not_active Expired - Lifetime
-
1991
- 1991-12-06 AU AU91403/91A patent/AU652211B2/en not_active Ceased
- 1991-12-06 AT AT92902095T patent/ATE196925T1/de not_active IP Right Cessation
- 1991-12-06 CA CA002097698A patent/CA2097698C/en not_active Expired - Lifetime
- 1991-12-06 EP EP92902095A patent/EP0574406B1/en not_active Expired - Lifetime
- 1991-12-06 WO PCT/US1991/009308 patent/WO1992010571A1/en not_active Ceased
- 1991-12-06 JP JP4502732A patent/JP2966093B2/ja not_active Expired - Lifetime
- 1991-12-06 DK DK92902095T patent/DK0574406T3/da active
- 1991-12-06 DE DE69132447T patent/DE69132447T2/de not_active Expired - Fee Related
- 1991-12-06 FI FI932573A patent/FI932573L/fi unknown
-
1993
- 1993-06-04 NO NO19932057A patent/NO311363B1/no unknown
-
1994
- 1994-11-03 US US08/333,977 patent/US5594108A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU652211B2 (en) | 1994-08-18 |
| US5594108A (en) | 1997-01-14 |
| DE69132447T2 (de) | 2001-03-08 |
| DE69132447D1 (de) | 2000-11-16 |
| EP0574406B1 (en) | 2000-10-11 |
| CA2097698C (en) | 1999-06-01 |
| JP2966093B2 (ja) | 1999-10-25 |
| WO1992010571A1 (en) | 1992-06-25 |
| EP0574406A1 (en) | 1993-12-22 |
| CA2097698A1 (en) | 1992-06-08 |
| FI932573A7 (fi) | 1993-07-09 |
| FI932573L (fi) | 1993-07-09 |
| ATE196925T1 (de) | 2000-10-15 |
| US5422265A (en) | 1995-06-06 |
| FI932573A0 (fi) | 1993-06-04 |
| DK0574406T3 (da) | 2000-11-13 |
| AU9140391A (en) | 1992-07-08 |
| JPH06503958A (ja) | 1994-05-12 |
| NO311363B1 (no) | 2001-11-19 |
| NO932057D0 (no) | 1993-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO932057L (no) | Ny dopamin-menneske-reseptor og dens anvendelser | |
| WO1994003602A3 (en) | A novel human dopamine receptor and its uses | |
| NO943775L (no) | Melanocyt stimulerende hormon reseptor og anvendelse derav | |
| WO1995006743A3 (en) | Methods and compositions for the large scale production of recombinant adeno-associated virus | |
| HUP9902310A2 (hu) | Komplementer adenovírus-vektorrendszerek és sejtvonalak | |
| BR0009392A (pt) | Polipeptìdeo, sequência de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir uma sequência de ácido nucleico mutante e para produzir um polipeptìdeo, mutante de um polipeptìdeo com atividade de alafa-amilase, e, uso do polipeptìdeo ou variante | |
| DK1792982T3 (da) | Codon-optimeret phosphatase og ekspression heraf i gær | |
| PT728214E (pt) | Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado | |
| AU4241697A (en) | Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat | |
| EP0232112A3 (en) | Recombinant protein complex having human factor viii:c activity its production and use | |
| DE3750125D1 (de) | Biologische eindämmung. | |
| PT851926E (pt) | Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada | |
| IE801137L (en) | Dna transfer vector | |
| DK0856581T3 (da) | Stabilt transficerede cellelinjer, der udtrykker GABA-A-receptorer | |
| DK0811071T3 (da) | Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner | |
| DK109180A (da) | Peptider med ubiquitin-lignende aktivitet og fremgangsmaade til fremstilling deraf | |
| GB9919409D0 (en) | Baculovirus expression system | |
| CA2133845A1 (en) | Adrenocorticotrophic hormone receptor and uses | |
| HUP9801438A2 (hu) | Növényekben előállított rekombináns preduodenális lipázok és polipeptid-származékaik, előállításuk és alkalmazásuk | |
| AU1242188A (en) | Isolation of single chain proteins with fsh suppressing activity from follicular fluid | |
| DE3577994D1 (de) | Vergroessernde virale dna-segmente. | |
| DK1196560T3 (da) | Neurotrofisk faktor receptor GFR-alfa-4 | |
| DE69634757D1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
| HU9500619D0 (en) | Cloning and expression of b-app-c100 receptor | |
| PT870015E (pt) | Novas xilanases os genes que as codificam e as suas utilizacoes |